Biomarker Clinical Trials

12 recruiting

Biomarker Trials at a Glance

74 actively recruiting trials for biomarker are listed on ClinicalTrialsFinder across 6 cities in 26 countries. The largest study group is Not Applicable with 26 trials, with the heaviest enrollment activity in Beijing, Guangzhou, and Fuzhou. Lead sponsors running biomarker studies include Nanfang Hospital, Southern Medical University, Cuibai Wei,Clinical Professor, and Centre Hospitalier Universitaire, Amiens.

Browse biomarker trials by phase

Treatments under study

About Biomarker Clinical Trials

Looking for clinical trials for Biomarker? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Biomarker trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Biomarker clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 74 trials

Recruiting
Not Applicable

VertiGreens Investigating the Effects of Iron Biofortification of Microgreens on Iron Status in Women

Iron Biomarkers/Status
University of Aberdeen30 enrolled1 locationNCT06972927
Recruiting
Not Applicable

Effects Of Dietary Fats on Gut Microbiota Composition and Metabolic Activity in Healthy Adults

Inflammation BiomarkersGut Microbiota Diversity and CompositionShort Chain Fatty Acids Concentration in Stools+1 more
University of Glasgow64 enrolled1 locationNCT07550023
Recruiting

Discovery and Validation of Periodontitis Biomarkers

PeriodontitisBiomarker in Early DiagnosisSaliva
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University228 enrolled1 locationNCT07293481
Recruiting
Not Applicable

Hepatoprotective Effects of Reishi Mushroom- (Ganoderma Lucidum) Among Metabolic Dysfunction-associated Fatty Liver Disease Patients

Lipid ProfileLiver Biomarkers
University of Lahore102 enrolled1 locationNCT07534241
Recruiting
Not Applicable

COronoary Microcirculation Analysis NETwork

Coronary Artery DiseaseEchocardiographyMicrocirculation Resistance+4 more
Medical University of Bialystok180 enrolled1 locationNCT07498231
Recruiting

Analysis of Inflammatory Biomarker Changes in Dry Blood Spot Versus Venous Blood Samples

InflammationInflammation BiomarkersBlood Sampling+1 more
McGill University Health Centre/Research Institute of the McGill University Health Centre50 enrolled1 locationNCT07435285
Recruiting
Not Applicable

Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

Biomarkers / BloodAsthma ExacerbationsEosinophil Blood Count
National Healthcare Group Polyclinics240 enrolled1 locationNCT07486401
Recruiting
Not Applicable

Berberine Supplementation, Sprint Interval Training, and Immune Function Study

Inflammation BiomarkersWellbeingBerberine+3 more
University of Northern Colorado40 enrolled1 locationNCT07480018
Recruiting

Expanded Studies on the SCAPIS Stockholm Reexamination Cohort

Heart FailureCoronary Artery DiseaseOral Microbiota+9 more
Danderyd Hospital1,400 enrolled1 locationNCT07476703
Recruiting
Not Applicable

Effect of Ginger Capsules on Inflammation, Oxidative Stress, and Endothelial Function

Cardiometabolic Risk FactorsOxidative StressInflammation Biomarkers
Ana Mª Garcia Munoz50 enrolled1 locationNCT07437222
Recruiting

Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients

Lung AdenocarcinomaPleural EffusionBiomarkers
Fu Jen Catholic University100 enrolled1 locationNCT07012759
Recruiting
Not Applicable

Effect of a Ginger-Based Beverage on Inflammation, Oxidative Stress, and Endothelial Function

Cardiometabolic Risk FactorsOxidative StressInflammation Biomarkers
Javier Marhuenda50 enrolled1 locationNCT07433998
Recruiting

Inflammatory Biomarkers and Postoperative Delirium in Pediatric Circumcision

Postoperative DeliriumPediatric AnesthesiaInflammatory Biomarkers
Ankara Etlik City Hospital140 enrolled1 locationNCT07323485
Recruiting
Not Applicable

A Study of a Dietary Supplement on Serum Biomarkers in Children

Nutritional StatusSerum Biomarkers
SF Research Institute, Inc.30 enrolled1 locationNCT07385144
Recruiting

Tennessee Alzheimer's Project

DementiaCognitive DysfunctionAlzheimer Disease+4 more
Vanderbilt University Medical Center1,000 enrolled1 locationNCT05372172
Recruiting
Not Applicable

miR-342-5p/AnkG Pathway in Early AD Synaptic Dysfunction

Alzheimer DiseaseBiomarker in Early Diagnosis
The Fourth Affiliated Hospital of Zhejiang University School of Medicine40 enrolled1 locationNCT07353502
Recruiting

Thrombus Composition in Ischemic Stroke: Analysis of the Correlation With Plasma Biomarkers, Efficacy of Treatment, Etiology and Prognosis

PrognosisBiomarkersStroke, Acute+2 more
Fondation Ophtalmologique Adolphe de Rothschild1,200 enrolled12 locationsNCT03268668
Recruiting

Clinical Aspects, Management and Surveillance of Febrile Illnesses in DRC

BiomarkersSurveillanceFebrile Illness Acute
Institute of Tropical Medicine, Belgium500 enrolled1 locationNCT07345286
Recruiting
Phase 3

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

EpilepsyAlzheimer DiseaseSeizures+7 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau120 enrolled5 locationsNCT07234695
Recruiting
Not Applicable

Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock

InfectionSeptic ShockBiomarker+2 more
Centre Hospitalier Universitaire, Amiens144 enrolled1 locationNCT07203833